Insulin-like growth factor-I (IGF-I) is essential for normal growth; igf-1 gene mutations are associated with extreme growth retardation in mice and, very rarely, in humans. The relative contributions of tissue vs. endocrine (hepatic) IGF-I to the regulation of growth has been a fundamental question. New gene targeting technologies are providing answers for these questions.
|Original language||English (US)|
|Number of pages||4|
|Journal||News in Physiological Sciences|
|State||Published - Apr 1 2002|
ASJC Scopus subject areas